PROPAFENONE

PROPAFENONE was reported 4285 times

PROPAFENONE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BRONCHIAL MUCOSA HYPERAEMIA 4 0.4444
1 ENZYME INDUCTION 11 0.2292
2 ELECTROCARDIOGRAM PQ INTERVAL PROLONGED 15 0.1613
3 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE 5 0.1316
4 ENZYME ACTIVITY INCREASED 4 0.1250
5 HYPERFIBRINOGENAEMIA 5 0.0746
6 DRUG-DEVICE INTERACTION 7 0.0631
7 BLOOD IMMUNOGLOBULIN E DECREASED 9 0.0559
8 MEAN CELL HAEMOGLOBIN CONCENTRATION ABNORMAL 9 0.0559
9 MUSCLE FIBROSIS 4 0.0548
10 HYPERKINETIC HEART SYNDROME 3 0.0508
11 PH BODY FLUID ABNORMAL 7 0.0504
12 VENTRICULAR ASYSTOLE 8 0.0460
13 FIBRINOLYSIS 3 0.0441
14 TRIFASCICULAR BLOCK 4 0.0367
15 EYELID EROSION 3 0.0345
16 NEONATAL PNEUMONIA 8 0.0340
17 BUNDLE BRANCH BLOCK BILATERAL 3 0.0312
18 CORNEAL DEFECT 4 0.0303
19 KERATOACANTHOMA 20 0.0292
20 BRAIN SCAN ABNORMAL 16 0.0287
21 CELL-MEDIATED IMMUNE DEFICIENCY 4 0.0286
22 RHYTHM IDIOVENTRICULAR 9 0.0277
23 ADNEXA UTERI MASS 8 0.0277
24 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 140 0.0273
25 CEREBRAL ARTERY THROMBOSIS 14 0.0272
26 NODAL ARRHYTHMIA 21 0.0244
27 NODULAR MELANOMA 4 0.0231
28 GROIN INFECTION 12 0.0218
29 NEONATAL HYPOTENSION 8 0.0217
30 ELECTROCARDIOGRAM P WAVE ABNORMAL 5 0.0204
31 CENTRAL NERVOUS SYSTEM HAEMORRHAGE 9 0.0193
32 MINERAL METABOLISM DISORDER 3 0.0189
33 CARDIAC ASSISTANCE DEVICE USER 7 0.0186
34 DEFECT CONDUCTION INTRAVENTRICULAR 6 0.0185
35 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 9 0.0172
36 INTESTINAL ADENOCARCINOMA 3 0.0160
37 FACIAL ASYMMETRY 15 0.0157
38 DUPLICATE THERAPY ERROR 5 0.0156
39 LEUKOPLAKIA ORAL 7 0.0136
40 BRUGADA SYNDROME 14 0.0135
41 GENITAL EROSION 4 0.0135
42 SYSTOLIC DYSFUNCTION 14 0.0133
43 ELECTROCARDIOGRAM PR PROLONGATION 10 0.0131
44 COAGULATION TEST ABNORMAL 10 0.0130
45 VOCAL CORD THICKENING 4 0.0126
46 SPINAL CORD HAEMORRHAGE 5 0.0125
47 ANTICOAGULATION DRUG LEVEL INCREASED 4 0.0125
48 DRUG-GENETIC INTERACTION 4 0.0112
49 OROPHARYNGEAL PLAQUE 4 0.0099
50 VISCERAL CONGESTION 5 0.0098
51 INTERLEUKIN LEVEL INCREASED 5 0.0091
52 MUSCLE ENZYME INCREASED 4 0.0090
53 ATRIOVENTRICULAR BLOCK FIRST DEGREE 39 0.0090
54 ENANTHEMA 5 0.0087
55 BRADYARRHYTHMIA 14 0.0085
56 ISCHAEMIC HEPATITIS 11 0.0080
57 VENTRICULAR ARRHYTHMIA 28 0.0076
58 AREFLEXIA 20 0.0075
59 BLOOD IMMUNOGLOBULIN A INCREASED 4 0.0074
60 HYPOCAPNIA 3 0.0072
61 LARYNGEAL STENOSIS 4 0.0069
62 GINGIVAL BLISTER 3 0.0068
63 DRUG-DISEASE INTERACTION 5 0.0068
64 CHOLESTATIC LIVER INJURY 15 0.0067
65 TROPONIN I INCREASED 11 0.0066
66 HYDROPS FOETALIS 4 0.0065
67 TACHYARRHYTHMIA 16 0.0064
68 ARRHYTHMIA SUPRAVENTRICULAR 7 0.0064
69 ATRIAL TACHYCARDIA 13 0.0062
70 NASAL CRUSTING 4 0.0062
71 DIASTOLIC DYSFUNCTION 19 0.0061
72 NODAL RHYTHM 9 0.0061
73 SPUTUM PURULENT 4 0.0061
74 HYPERCREATININAEMIA 3 0.0060
75 BUNDLE BRANCH BLOCK RIGHT 27 0.0059
76 SINUS ARREST 9 0.0057
77 CARDIOVERSION 8 0.0057
78 SINUS BRADYCARDIA 54 0.0056
79 RESPIRATORY DISORDER NEONATAL 9 0.0055
80 SYPHILIS 4 0.0055
81 LIP EROSION 4 0.0055
82 RIGHT VENTRICULAR DYSFUNCTION 6 0.0054
83 ATRIAL FLUTTER 43 0.0054
84 HAEMORRHAGIC ARTERIOVENOUS MALFORMATION 5 0.0053
85 BLOOD LOSS ANAEMIA 12 0.0053
86 FLAT AFFECT 12 0.0052
87 COAGULATION TIME PROLONGED 8 0.0052
88 DILATATION ATRIAL 6 0.0051
89 HYPOCOAGULABLE STATE 5 0.0051
90 VENTRICULAR TACHYCARDIA 84 0.0051
91 PSYCHOMOTOR RETARDATION 14 0.0050
92 CONDUCTION DISORDER 9 0.0049
93 INFECTIOUS MONONUCLEOSIS 11 0.0049
94 CARDIAC FIBRILLATION 7 0.0048
95 ACUTE LEFT VENTRICULAR FAILURE 3 0.0045
96 SICK SINUS SYNDROME 5 0.0043
97 PROCALCITONIN INCREASED 5 0.0043
98 BUNDLE BRANCH BLOCK LEFT 18 0.0042
99 ELECTROCARDIOGRAM CHANGE 4 0.0042
100 MYOCARDIAL NECROSIS MARKER INCREASED 7 0.0042
101 HYPERLACTACIDAEMIA 11 0.0041
102 SUPRAVENTRICULAR TACHYCARDIA 38 0.0040
103 CARDIAC ABLATION 7 0.0039
104 ATRIOVENTRICULAR BLOCK COMPLETE 26 0.0039
105 ATRIAL FIBRILLATION 359 0.0037
106 HAEMODYNAMIC INSTABILITY 28 0.0037
107 PERICARDIAL HAEMORRHAGE 8 0.0037
108 ELECTROCARDIOGRAM ABNORMAL 28 0.0036
109 GASTROINTESTINAL ULCER HAEMORRHAGE 4 0.0036
110 NONINFECTIVE GINGIVITIS 5 0.0035
111 COMA SCALE ABNORMAL 10 0.0034
112 SUBARACHNOID HAEMORRHAGE 34 0.0033
113 SLEEP DEFICIT 7 0.0033
114 VESTIBULAR DISORDER 4 0.0033
115 BRADYCARDIA 172 0.0032
116 HAEMORRHAGIC ANAEMIA 14 0.0032
117 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 28 0.0032
118 EXTRASYSTOLES 22 0.0031
119 GASTRITIS EROSIVE 14 0.0030
120 ARRHYTHMIA 142 0.0030
121 LOWER GASTROINTESTINAL HAEMORRHAGE 22 0.0030
122 GENERALISED TONIC-CLONIC SEIZURE 49 0.0030
123 BRAIN STEM INFARCTION 3 0.0029
124 PUSTULAR PSORIASIS 10 0.0029
125 LIGHT CHAIN ANALYSIS INCREASED 3 0.0029
126 POOR PERIPHERAL CIRCULATION 12 0.0028
127 PORPHYRIA ACUTE 4 0.0028
128 HEART RATE IRREGULAR 63 0.0028
129 NORMOCYTIC ANAEMIA 4 0.0027
130 BODY TEMPERATURE ABNORMAL 5 0.0027
131 APRAXIA 4 0.0027
132 DIVERTICULUM INTESTINAL HAEMORRHAGIC 6 0.0027
133 HYPOPROTEINAEMIA 5 0.0026
134 CONJUNCTIVAL HAEMORRHAGE 10 0.0026
135 MYOGLOBIN BLOOD INCREASED 4 0.0026
136 LICHEN PLANUS 6 0.0026
137 ORAL MUCOSAL ERYTHEMA 4 0.0026
138 NEOPLASM SKIN 4 0.0026
139 HYPORESPONSIVE TO STIMULI 3 0.0026
140 BRADYKINESIA 15 0.0025
141 HAEMORRHAGE SUBCUTANEOUS 9 0.0025
142 FAECAL CALPROTECTIN INCREASED 8 0.0025
143 INFECTED CYST 3 0.0025
144 AORTIC VALVE DISEASE 4 0.0025
145 TENSION 15 0.0025
146 RESPIRATORY ALKALOSIS 4 0.0025
147 ATRIOVENTRICULAR BLOCK 19 0.0025
148 GRANULOCYTOPENIA 14 0.0025
149 QUADRIPLEGIA 5 0.0024
150 DRUG LEVEL INCREASED 40 0.0024
151 ENDODONTIC PROCEDURE 6 0.0024
152 LEFT ATRIAL DILATATION 3 0.0024
153 VENTRICULAR FIBRILLATION 26 0.0023
154 INTERNATIONAL NORMALISED RATIO ABNORMAL 8 0.0023
155 ATRIOVENTRICULAR BLOCK SECOND DEGREE 7 0.0023
156 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 5 0.0023
157 ANION GAP INCREASED 3 0.0022
158 OVERWEIGHT 12 0.0022
159 CARDIOGENIC SHOCK 32 0.0022
160 INTERNATIONAL NORMALISED RATIO DECREASED 9 0.0022
161 OPHTHALMIC HERPES ZOSTER 4 0.0022
162 SINUS NODE DYSFUNCTION 4 0.0022
163 PANCREATITIS NECROTISING 5 0.0022
164 CARDIAC FLUTTER 14 0.0022
165 BLOOD ELECTROLYTES DECREASED 3 0.0021
166 LEFT VENTRICULAR HYPERTROPHY 9 0.0021
167 PARTIAL SEIZURES 11 0.0021
168 METABOLIC ACIDOSIS 67 0.0021
169 PULSE ABNORMAL 5 0.0021
170 LABELLED DRUG-DRUG INTERACTION ISSUE 3 0.0021
171 SUPRAVENTRICULAR EXTRASYSTOLES 7 0.0021
172 DRUG INTERACTION 327 0.0021
173 BASAL CELL CARCINOMA 32 0.0020
174 LEFT VENTRICULAR FAILURE 7 0.0020
175 GASTRITIS HAEMORRHAGIC 3 0.0020
176 INTESTINAL ISCHAEMIA 11 0.0020
177 STREPTOCOCCAL INFECTION 11 0.0020
178 DYSLIPIDAEMIA 10 0.0020
179 PRODUCT CONTAMINATION 7 0.0020
180 DERMATITIS PSORIASIFORM 4 0.0020
181 NEPHROGENIC ANAEMIA 9 0.0019
182 ATRIAL THROMBOSIS 4 0.0019
183 VENTRICULAR EXTRASYSTOLES 20 0.0019
184 ELECTROCARDIOGRAM QT PROLONGED 68 0.0019
185 FACIAL PARALYSIS 16 0.0019
186 PURULENT DISCHARGE 8 0.0019
187 UPPER GASTROINTESTINAL HAEMORRHAGE 31 0.0018
188 HEMIPLEGIA 15 0.0018
189 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 12 0.0018
190 TRICUSPID VALVE INCOMPETENCE 14 0.0018
191 MYOCARDIAL ISCHAEMIA 20 0.0018
192 PRODUCT TEMPERATURE EXCURSION ISSUE 9 0.0017
193 PHARYNGEAL DISORDER 5 0.0017
194 EMOTIONAL POVERTY 3 0.0017
195 SUSPECTED SUICIDE 8 0.0017
196 SELF-MEDICATION 7 0.0017
197 FOOD INTERACTION 3 0.0017
198 SQUAMOUS CELL CARCINOMA 16 0.0017
199 THORACIC VERTEBRAL FRACTURE 5 0.0017
200 FIBRIN D DIMER INCREASED 6 0.0017
201 CARDIAC TAMPONADE 8 0.0017
202 CONJUNCTIVAL HYPERAEMIA 6 0.0017
203 INTRA-ABDOMINAL HAEMORRHAGE 4 0.0017
204 LONG QT SYNDROME 4 0.0017
205 NORMOCHROMIC NORMOCYTIC ANAEMIA 5 0.0017
206 PLATELET COUNT ABNORMAL 10 0.0017
207 KERATITIS 5 0.0016
208 LOW BIRTH WEIGHT BABY 13 0.0016
209 AMYLASE INCREASED 6 0.0016
210 ISCHAEMIC STROKE 29 0.0016
211 SMALL FOR DATES BABY 8 0.0016
212 VENOOCCLUSIVE DISEASE 4 0.0016
213 CORONARY ARTERY STENOSIS 8 0.0016
214 LABYRINTHITIS 4 0.0016
215 CARDIAC ARREST 129 0.0016
216 SKIN EROSION 5 0.0016
217 ALCOHOL INTERACTION 3 0.0015
218 VENTRICULAR DYSFUNCTION 4 0.0015
219 PROSTATOMEGALY 6 0.0015
220 HYPERAEMIA 3 0.0015
221 BLOOD LACTIC ACID INCREASED 8 0.0015
222 PROTHROMBIN TIME PROLONGED 9 0.0015
223 HEPATITIS CHOLESTATIC 9 0.0015
224 HAEMATURIA 51 0.0015
225 GINGIVITIS 8 0.0015
226 TOXICITY TO VARIOUS AGENTS 248 0.0015
227 INJECTION SITE INJURY 8 0.0014
228 EOSINOPHIL COUNT INCREASED 12 0.0014
229 COMPLETED SUICIDE 119 0.0014
230 MUSCLE CONTRACTIONS INVOLUNTARY 5 0.0014
231 NEUTROPHILIA 8 0.0014
232 INTERNATIONAL NORMALISED RATIO INCREASED 40 0.0014
233 EYELID MARGIN CRUSTING 4 0.0014
234 DIVERTICULUM INTESTINAL 6 0.0014
235 ELECTROCARDIOGRAM T WAVE INVERSION 3 0.0014
236 HYPERTENSIVE CRISIS 15 0.0013
237 CARDIOTOXICITY 12 0.0013
238 LARGE INTESTINAL HAEMORRHAGE 3 0.0013
239 SCRATCH 14 0.0013
240 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 8 0.0013
241 AORTIC ANEURYSM 10 0.0013
242 ISCHAEMIA 6 0.0013
243 ERYTHEMA OF EYELID 7 0.0013
244 ALTERED STATE OF CONSCIOUSNESS 28 0.0013
245 HAEMORRHAGIC STROKE 10 0.0013
246 EYE HAEMORRHAGE 17 0.0013
247 RESPIRATORY RATE DECREASED 4 0.0013
248 RESPIRATORY ACIDOSIS 5 0.0013
249 GASTRIC ULCER HAEMORRHAGE 7 0.0013
250 ORTHOPNOEA 4 0.0013
251 MITRAL VALVE INCOMPETENCE 14 0.0012
252 INTENTIONAL OVERDOSE 78 0.0012
253 VENOOCCLUSIVE LIVER DISEASE 6 0.0012
254 DRUG-INDUCED LIVER INJURY 38 0.0012
255 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 4 0.0012
256 HYPERNATRAEMIA 6 0.0012
257 HYPERPARATHYROIDISM SECONDARY 3 0.0012
258 PRESYNCOPE 29 0.0012
259 TROPONIN INCREASED 9 0.0012
260 PRODUCT DISPENSING ISSUE 5 0.0012
261 AORTIC ARTERIOSCLEROSIS 3 0.0012
262 BLOOD CHLORIDE DECREASED 3 0.0012
263 ANURIA 10 0.0012
264 TORSADE DE POINTES 9 0.0011
265 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 3 0.0011
266 JAUNDICE CHOLESTATIC 4 0.0011
267 SHOCK 26 0.0011
268 NEONATAL RESPIRATORY DISTRESS SYNDROME 4 0.0011
269 GLOSSITIS 4 0.0011
270 ALCOHOL POISONING 3 0.0011
271 BRADYPNOEA 3 0.0011
272 IRON DEFICIENCY 5 0.0011
273 SPLENOMEGALY 13 0.0011
274 ABDOMINAL RIGIDITY 3 0.0011
275 EMBOLISM 9 0.0011
276 MENTAL STATUS CHANGES 30 0.0011
277 OBSTRUCTIVE AIRWAYS DISORDER 12 0.0011
278 HEART RATE ABNORMAL 6 0.0011
279 SYNCOPE 107 0.0011
280 TRANSIENT ISCHAEMIC ATTACK 36 0.0011
281 TOXIC EPIDERMAL NECROLYSIS 16 0.0011
282 PULSE ABSENT 5 0.0011
283 HEART VALVE INCOMPETENCE 3 0.0010
284 BREAST MASS 7 0.0010
285 MOUTH SWELLING 6 0.0010
286 DYSPNOEA AT REST 3 0.0010
287 GASTROINTESTINAL HAEMORRHAGE 86 0.0010
288 COAGULOPATHY 17 0.0010
289 CARDIOMYOPATHY 15 0.0010
290 CARDIAC PACEMAKER INSERTION 6 0.0010
291 METABOLIC ENCEPHALOPATHY 3 0.0010
292 CREATININE RENAL CLEARANCE DECREASED 4 0.0010
293 EMERGENCY CARE 3 0.0010
294 HYPERURICAEMIA 4 0.0010
295 VARICOSE VEIN 5 0.0010
296 FOETAL DEATH 5 0.0010
297 THERAPY PARTIAL RESPONDER 15 0.0010
298 RHABDOMYOLYSIS 40 0.0010
299 PETECHIAE 10 0.0010
300 PULSELESS ELECTRICAL ACTIVITY 4 0.0010
301 SUICIDE ATTEMPT 58 0.0010
302 SERUM FERRITIN INCREASED 5 0.0009
303 GOUT 17 0.0009
304 PALPITATIONS 107 0.0009
305 PULMONARY HYPERTENSION 19 0.0009
306 HEART RATE DECREASED 32 0.0009
307 LISTLESS 3 0.0009
308 CARDIO-RESPIRATORY ARREST 38 0.0009
309 ON AND OFF PHENOMENON 5 0.0009
310 HYPOALBUMINAEMIA 7 0.0009
311 ACUTE PULMONARY OEDEMA 5 0.0009
312 HYPOTHERMIA 9 0.0009
313 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 9 0.0009
314 HAEMATOCHEZIA 48 0.0009
315 BLOOD CREATININE ABNORMAL 3 0.0009
316 AORTIC STENOSIS 3 0.0009
317 HYPOTENSION 172 0.0009
318 EPISTAXIS 64 0.0009
319 HANGOVER 3 0.0009
320 CLOSTRIDIUM DIFFICILE COLITIS 9 0.0008
321 HEART DISEASE CONGENITAL 3 0.0008
322 SINUS TACHYCARDIA 12 0.0008
323 ODYNOPHAGIA 5 0.0008
324 HYPOVOLAEMIC SHOCK 4 0.0008
325 FACIAL BONES FRACTURE 3 0.0008
326 SQUAMOUS CELL CARCINOMA OF SKIN 5 0.0008
327 RECTAL HAEMORRHAGE 35 0.0008
328 LOSS OF CONSCIOUSNESS 104 0.0008
329 ACUTE KIDNEY INJURY 124 0.0008
330 PIGMENTATION DISORDER 5 0.0008
331 LIGAMENT SPRAIN 8 0.0008
332 DEPRESSED LEVEL OF CONSCIOUSNESS 32 0.0008
333 DIPLOPIA 21 0.0008
334 HAEMATOCRIT DECREASED 16 0.0008
335 BLOOD PRESSURE ABNORMAL 16 0.0008
336 HAEMORRHAGE INTRACRANIAL 12 0.0008
337 RESPIRATORY DISTRESS 22 0.0008
338 SWELLING OF EYELID 5 0.0008
339 AUTOIMMUNE THYROIDITIS 3 0.0008
340 BRAIN OEDEMA 10 0.0008
341 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 4 0.0008
342 INTERNAL HAEMORRHAGE 9 0.0008
343 ACIDOSIS 6 0.0008
344 COMA 37 0.0008
345 LYMPHOMA 12 0.0008
346 UNRESPONSIVE TO STIMULI 20 0.0008
347 POST PROCEDURAL HAEMORRHAGE 9 0.0008
348 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 6 0.0008
349 PALLOR 21 0.0008
350 CARDIOPULMONARY FAILURE 3 0.0008
351 SUBDURAL HAEMATOMA 11 0.0008
352 SPINAL PAIN 9 0.0008
353 CYANOSIS 12 0.0008
354 ASPERGILLUS INFECTION 5 0.0008
355 HYPERTHYROIDISM 11 0.0008
356 HYPOKINESIA 11 0.0008
357 LEFT VENTRICULAR DYSFUNCTION 5 0.0007
358 COMPRESSION FRACTURE 4 0.0007
359 PRODUCT SIZE ISSUE 4 0.0007
360 STENT PLACEMENT 6 0.0007
361 HYPERKALAEMIA 26 0.0007
362 APPLICATION SITE DISCOLOURATION 3 0.0007
363 ACCIDENTAL OVERDOSE 27 0.0007
364 SHOCK HAEMORRHAGIC 6 0.0007
365 TACHYPNOEA 10 0.0007
366 TACHYCARDIA 65 0.0007
367 HYPERKERATOSIS 4 0.0007
368 AORTIC DISSECTION 3 0.0007
369 LARGE INTESTINE POLYP 5 0.0007
370 ACCIDENTAL EXPOSURE 3 0.0007
371 HEPATOTOXICITY 16 0.0007
372 ANGIOPATHY 4 0.0007
373 PULMONARY ALVEOLAR HAEMORRHAGE 4 0.0007
374 LIP OEDEMA 3 0.0007
375 AORTIC VALVE INCOMPETENCE 3 0.0007
376 DIVERTICULUM 5 0.0007
377 HIATUS HERNIA 9 0.0007
378 SKIN ATROPHY 4 0.0007
379 CARDIAC MURMUR 6 0.0007
380 PERICARDIAL EFFUSION 16 0.0007
381 METABOLIC DISORDER 4 0.0007
382 EYELID OEDEMA 8 0.0007
383 STRESS CARDIOMYOPATHY 4 0.0007
384 SEIZURE 79 0.0007
385 SLEEP APNOEA SYNDROME 13 0.0007
386 PRODUCT TASTE ABNORMAL 9 0.0007
387 CHROMATURIA 15 0.0007
388 PREMATURE BABY 20 0.0007
389 ANGINA PECTORIS 19 0.0007
390 HAEMOGLOBIN INCREASED 3 0.0007
391 HAEMATOMA 17 0.0007
392 LUMBAR VERTEBRAL FRACTURE 3 0.0007
393 HYPOXIA 23 0.0007
394 HIP FRACTURE 21 0.0007
395 BREAST CANCER METASTATIC 7 0.0007
396 GLOMERULAR FILTRATION RATE DECREASED 8 0.0007
397 LOCALISED OEDEMA 3 0.0006
398 FEELING OF DESPAIR 3 0.0006
399 PRODUCT PRESCRIBING ISSUE 14 0.0006
400 DISSEMINATED INTRAVASCULAR COAGULATION 9 0.0006
401 HYPOCALCAEMIA 12 0.0006
402 COLITIS 24 0.0006
403 ORTHOSTATIC HYPOTENSION 11 0.0006
404 BRONCHOSPASM 9 0.0006
405 BALANCE DISORDER 54 0.0006
406 BLOOD DISORDER 5 0.0006
407 PULMONARY ARTERIAL HYPERTENSION 9 0.0006
408 INCOHERENT 4 0.0006
409 ANGINA UNSTABLE 4 0.0006
410 HEPATOMEGALY 6 0.0006
411 BODY TEMPERATURE DECREASED 6 0.0006
412 INABILITY TO AFFORD MEDICATION 6 0.0006
413 MULTIPLE ORGAN DYSFUNCTION SYNDROME 17 0.0006
414 BLOOD UREA INCREASED 10 0.0006
415 HEART RATE INCREASED 59 0.0006
416 HYPOTHYROIDISM 19 0.0006
417 PRODUCT LABEL ISSUE 4 0.0006
418 DISEASE RECURRENCE 28 0.0006
419 CARDIAC FAILURE 47 0.0006
420 INFARCTION 4 0.0006
421 BLOOD SODIUM DECREASED 11 0.0006
422 NEPHROTIC SYNDROME 4 0.0006
423 ECCHYMOSIS 4 0.0006
424 CORONARY ARTERY OCCLUSION 8 0.0006
425 CEREBRAL ISCHAEMIA 3 0.0006
426 EJECTION FRACTION DECREASED 9 0.0006
427 HYSTERECTOMY 5 0.0006
428 AUTOIMMUNE HEPATITIS 4 0.0006
429 PRODUCT SUBSTITUTION ISSUE 33 0.0006
430 BLOOD PRESSURE DECREASED 38 0.0006
431 HYPONATRAEMIA 32 0.0006
432 COLD SWEAT 10 0.0006
433 MUSCLE TWITCHING 13 0.0006
434 ANAL FISTULA 3 0.0006
435 BODY HEIGHT DECREASED 6 0.0006
436 ANAL FISSURE 3 0.0006
437 COGNITIVE DISORDER 26 0.0006
438 BRUXISM 3 0.0006
439 FAECES SOFT 4 0.0005
440 SPINAL FRACTURE 11 0.0005
441 MOUTH HAEMORRHAGE 4 0.0005
442 INCREASED TENDENCY TO BRUISE 5 0.0005
443 ABNORMAL DREAMS 15 0.0005
444 IRON DEFICIENCY ANAEMIA 5 0.0005
445 GRAND MAL CONVULSION 5 0.0005
446 DIZZINESS 269 0.0005
447 HEAD INJURY 17 0.0005
448 RESPIRATORY FAILURE 39 0.0005
449 SPEECH DISORDER 28 0.0005
450 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 4 0.0005
451 ANHEDONIA 14 0.0005
452 DYSPNOEA EXERTIONAL 20 0.0005
453 CONTRAINDICATED PRODUCT ADMINISTERED 16 0.0005
454 EXTRAPYRAMIDAL DISORDER 13 0.0005
455 PROCEDURAL COMPLICATION 4 0.0005
456 DRUG PRESCRIBING ERROR 10 0.0005
457 HYPERCHOLESTEROLAEMIA 5 0.0005
458 STAPHYLOCOCCAL INFECTION 17 0.0005
459 LUNG INFECTION 8 0.0005
460 ABDOMINAL PAIN LOWER 13 0.0005
461 APNOEA 4 0.0005
462 NERVOUS SYSTEM DISORDER 16 0.0005
463 ASTHENIA 192 0.0005
464 DRUG SCREEN POSITIVE 4 0.0005
465 MEDICATION ERROR 28 0.0005
466 BLOOD PRESSURE INCREASED 77 0.0005
467 RESPIRATORY TRACT INFECTION 13 0.0005
468 BLOOD PRESSURE INADEQUATELY CONTROLLED 3 0.0005
469 OXYGEN SATURATION DECREASED 28 0.0005
470 LEUKOCYTOSIS 9 0.0005
471 SENSORY LOSS 4 0.0005
472 TOXIC SKIN ERUPTION 5 0.0005
473 LYMPHOPENIA 7 0.0005
474 FOETAL GROWTH RESTRICTION 3 0.0005
475 ANAEMIA 94 0.0005
476 SPINAL COMPRESSION FRACTURE 4 0.0005
477 PHARYNGITIS 6 0.0005
478 CYST 6 0.0005
479 PAIN OF SKIN 13 0.0005
480 SLEEP DISORDER 34 0.0005
481 HALLUCINATION, VISUAL 10 0.0005
482 MUSCLE ATROPHY 6 0.0005
483 JOINT DISLOCATION 5 0.0005
484 ALANINE AMINOTRANSFERASE INCREASED 29 0.0005
485 SKIN HAEMORRHAGE 7 0.0005
486 RENAL FAILURE ACUTE 20 0.0005
487 RENAL INJURY 14 0.0005
488 DRY MOUTH 38 0.0005
489 JOINT INJURY 10 0.0005
490 THERAPY NON-RESPONDER 21 0.0005
491 GASTRIC DISORDER 16 0.0005
492 BLOOD MAGNESIUM DECREASED 4 0.0005
493 MYOPATHY 4 0.0005
494 BLOOD COUNT ABNORMAL 7 0.0005
495 SKIN LACERATION 5 0.0005
496 BACK INJURY 5 0.0005
497 DRUG DISPENSING ERROR 7 0.0005
498 HAEMOGLOBIN DECREASED 47 0.0005
499 URINE OUTPUT DECREASED 4 0.0005
500 INTERVERTEBRAL DISC PROTRUSION 10 0.0005
501 GASTRITIS 12 0.0005
502 GROIN PAIN 4 0.0005
503 SPINAL OSTEOARTHRITIS 4 0.0005
504 TOOTH INFECTION 6 0.0005
505 EMOTIONAL DISORDER 14 0.0005
506 CORONAVIRUS INFECTION 3 0.0005
507 ARTERIOSCLEROSIS CORONARY ARTERY 3 0.0005
508 APPETITE DISORDER 3 0.0005
509 ADVERSE REACTION 6 0.0005
510 MUSCULOSKELETAL CHEST PAIN 7 0.0005
511 RASH MACULO-PAPULAR 10 0.0004
512 CYTOKINE RELEASE SYNDROME 9 0.0004
513 ENCEPHALOPATHY 11 0.0004
514 BRONCHIECTASIS 3 0.0004
515 COLITIS ISCHAEMIC 3 0.0004
516 SINUS CONGESTION 6 0.0004
517 ACUTE MYOCARDIAL INFARCTION 13 0.0004
518 ABSCESS 7 0.0004
519 END STAGE RENAL DISEASE 8 0.0004
520 BLOOD TESTOSTERONE DECREASED 3 0.0004
521 EYE MOVEMENT DISORDER 3 0.0004
522 FALL 145 0.0004
523 HAEMATEMESIS 11 0.0004
524 ELECTROLYTE IMBALANCE 5 0.0004
525 DIARRHOEA HAEMORRHAGIC 4 0.0004
526 OVERDOSE 92 0.0004
527 GASTROOESOPHAGEAL REFLUX DISEASE 34 0.0004
528 LIP SWELLING 14 0.0004
529 RED BLOOD CELL COUNT DECREASED 12 0.0004
530 CEREBRAL HAEMORRHAGE 15 0.0004
531 HYPERLIPIDAEMIA 5 0.0004
532 SKIN CANCER 9 0.0004
533 LOWER LIMB FRACTURE 8 0.0004
534 ACUTE RESPIRATORY FAILURE 8 0.0004
535 FAECES DISCOLOURED 9 0.0004
536 SEPTIC SHOCK 18 0.0004
537 DYSPNOEA 234 0.0004
538 HYPOGLYCAEMIA 20 0.0004
539 FLUID OVERLOAD 6 0.0004
540 NECK PAIN 23 0.0004
541 HYPERHIDROSIS 53 0.0004
542 CIRCULATORY COLLAPSE 7 0.0004
543 MELAENA 9 0.0004
544 JAUNDICE 11 0.0004
545 CARDIOMEGALY 5 0.0004
546 NIGHT SWEATS 13 0.0004
547 SALIVARY HYPERSECRETION 4 0.0004
548 AMNESIA 26 0.0004
549 RESPIRATORY ARREST 11 0.0004
550 DIVERTICULITIS 11 0.0004
551 CHRONIC KIDNEY DISEASE 30 0.0004
552 HYPERTHERMIA 3 0.0004
553 HAEMOLYSIS 3 0.0004
554 PAIN IN JAW 11 0.0004
555 WHEEZING 23 0.0004
556 HYPERBILIRUBINAEMIA 4 0.0004
557 CARDIAC FAILURE CONGESTIVE 31 0.0004
558 OEDEMA PERIPHERAL 47 0.0004
559 SWOLLEN TONGUE 12 0.0004
560 HYPERGLYCAEMIA 14 0.0004
561 HERPES ZOSTER 22 0.0004
562 DERMATITIS 8 0.0004
563 TRANSFUSION 4 0.0004
564 CHEST DISCOMFORT 39 0.0004
565 PULMONARY CONGESTION 5 0.0004
566 MUSCULAR WEAKNESS 43 0.0004
567 CHEST PAIN 70 0.0004
568 RENAL PAIN 4 0.0004
569 PANCYTOPENIA 21 0.0004
570 HAIR TEXTURE ABNORMAL 5 0.0004
571 MOVEMENT DISORDER 12 0.0004
572 FLUID RETENTION 19 0.0004
573 MALIGNANT MELANOMA 5 0.0004
574 HAEMORRHAGE 39 0.0004
575 FLATULENCE 21 0.0004
576 FREQUENT BOWEL MOVEMENTS 10 0.0004
577 CEREBRAL INFARCTION 9 0.0004
578 PROTEINURIA 7 0.0004
579 BLOOD CREATININE INCREASED 24 0.0004
580 ACUTE HEPATIC FAILURE 5 0.0004
581 BLOOD POTASSIUM DECREASED 11 0.0004
582 EYE DISORDER 12 0.0004
583 CHOLESTASIS 7 0.0004
584 PERIPHERAL COLDNESS 5 0.0004
585 HAIR DISORDER 3 0.0004
586 DYSGEUSIA 27 0.0004
587 PHOTOSENSITIVITY REACTION 6 0.0004
588 SOMNOLENCE 73 0.0004
589 TREATMENT FAILURE 30 0.0004
590 ABDOMINAL PAIN 84 0.0004
591 GAMMA-GLUTAMYLTRANSFERASE INCREASED 8 0.0004
592 CEREBROVASCULAR ACCIDENT 61 0.0004
593 NERVE INJURY 4 0.0004
594 DEPRESSED MOOD 19 0.0004
595 FEELING COLD 10 0.0004
596 HAEMORRHOIDS 7 0.0004
597 PULMONARY OEDEMA 16 0.0004
598 ORAL PAIN 8 0.0004
599 PRODUCTIVE COUGH 17 0.0004
600 CARDIOVASCULAR DISORDER 9 0.0004
601 STATUS EPILEPTICUS 4 0.0004
602 CONTUSION 34 0.0004
603 UPPER LIMB FRACTURE 7 0.0004
604 TINNITUS 16 0.0003
605 IMPAIRED QUALITY OF LIFE 5 0.0003
606 GASTRIC HAEMORRHAGE 4 0.0003
607 BLOOD CREATINE PHOSPHOKINASE INCREASED 10 0.0003
608 PARAESTHESIA ORAL 5 0.0003
609 RENAL IMPAIRMENT 29 0.0003
610 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 18 0.0003
611 MADAROSIS 4 0.0003
612 MUSCULOSKELETAL PAIN 18 0.0003
613 NEUROTOXICITY 6 0.0003
614 GRIP STRENGTH DECREASED 3 0.0003
615 RIB FRACTURE 7 0.0003
616 DEHYDRATION 45 0.0003
617 ATAXIA 4 0.0003
618 DYSPEPSIA 33 0.0003
619 HAEMOLYTIC ANAEMIA 3 0.0003
620 CONSTIPATION 73 0.0003
621 DISTURBANCE IN ATTENTION 18 0.0003
622 BLOOD BILIRUBIN INCREASED 9 0.0003
623 INTENTIONAL PRODUCT MISUSE 29 0.0003
624 PNEUMONITIS 9 0.0003
625 BURSITIS 4 0.0003
626 EXOSTOSIS 3 0.0003
627 VISION BLURRED 45 0.0003
628 BRAIN NEOPLASM 3 0.0003
629 PULMONARY EMBOLISM 31 0.0003
630 THYROID DISORDER 5 0.0003
631 TENDON RUPTURE 4 0.0003
632 PRODUCT QUALITY ISSUE 44 0.0003
633 CONJUNCTIVITIS 6 0.0003
634 BLOOD ALKALINE PHOSPHATASE INCREASED 8 0.0003
635 MENTAL DISORDER 14 0.0003
636 CARDIAC DISORDER 30 0.0003
637 FLANK PAIN 3 0.0003
638 FOETAL EXPOSURE DURING PREGNANCY 26 0.0003
639 LACERATION 3 0.0003
640 POISONING 4 0.0003
641 DERMATITIS ALLERGIC 4 0.0003
642 BLOOD URINE PRESENT 6 0.0003
643 STEVENS-JOHNSON SYNDROME 7 0.0003
644 TRANSAMINASES INCREASED 7 0.0003
645 RASH MACULAR 11 0.0003
646 OBESITY 5 0.0003
647 OEDEMA 17 0.0003
648 INTRAOCULAR PRESSURE INCREASED 4 0.0003
649 HYPERTENSION 66 0.0003
650 ATELECTASIS 3 0.0003
651 ERUCTATION 6 0.0003
652 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 17 0.0003
653 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 22 0.0003
654 PNEUMONIA 100 0.0003
655 EAR PAIN 6 0.0003
656 BLOOD PRESSURE SYSTOLIC INCREASED 6 0.0003
657 TREMOR 51 0.0003
658 MEMORY IMPAIRMENT 42 0.0003
659 URINARY INCONTINENCE 9 0.0003
660 BLADDER DISORDER 3 0.0003
661 SOPOR 4 0.0003
662 ASPARTATE AMINOTRANSFERASE INCREASED 16 0.0003
663 PRESCRIBED UNDERDOSE 6 0.0003
664 HYPOTONIA 3 0.0003
665 BRAIN INJURY 3 0.0003
666 FEAR 8 0.0003
667 CORONARY ARTERY DISEASE 9 0.0003
668 INTENTIONAL SELF-INJURY 6 0.0003
669 FEEDING DISORDER 6 0.0003
670 PLEURAL EFFUSION 18 0.0003
671 DRY THROAT 3 0.0003
672 HEMIPARESIS 5 0.0003
673 PRODUCT PRESCRIBING ERROR 7 0.0003
674 GINGIVAL BLEEDING 4 0.0003
675 ABDOMINAL DISCOMFORT 49 0.0003
676 ABDOMINAL PAIN UPPER 60 0.0003
677 MULTI-ORGAN FAILURE 5 0.0003
678 NIGHTMARE 10 0.0003
679 MENTAL IMPAIRMENT 7 0.0003
680 PAIN IN EXTREMITY 85 0.0003
681 FEELING ABNORMAL 69 0.0003
682 URINARY TRACT INFECTION 49 0.0003
683 ROAD TRAFFIC ACCIDENT 12 0.0003
684 CARPAL TUNNEL SYNDROME 4 0.0003
685 INCONTINENCE 3 0.0003
686 PANCREATITIS 15 0.0003
687 WEIGHT DECREASED 79 0.0003
688 SKIN DISCOLOURATION 13 0.0003
689 HYPOKALAEMIA 13 0.0003
690 UPPER RESPIRATORY TRACT INFECTION 13 0.0003
691 GALLBLADDER DISORDER 5 0.0003
692 CONVULSION 16 0.0003
693 SKIN BURNING SENSATION 20 0.0003
694 VERTIGO 17 0.0003
695 HALLUCINATION 21 0.0003
696 DECREASED ACTIVITY 3 0.0003
697 PRURITUS GENERALISED 6 0.0003
698 MYELODYSPLASTIC SYNDROME 4 0.0003
699 TOOTHACHE 5 0.0003
700 WRONG TECHNIQUE IN DRUG USAGE PROCESS 10 0.0003
701 LIVER FUNCTION TEST ABNORMAL 8 0.0003
702 C-REACTIVE PROTEIN INCREASED 10 0.0003
703 NAUSEA 216 0.0003
704 THERAPY CESSATION 14 0.0003
705 DECREASED APPETITE 63 0.0003
706 SKIN ULCER 7 0.0003
707 EXPIRED PRODUCT ADMINISTERED 9 0.0003
708 DYSKINESIA 11 0.0003
709 SKIN DISORDER 9 0.0003
710 HEPATIC STEATOSIS 5 0.0003
711 OSTEOPOROSIS 11 0.0003
712 TUBULOINTERSTITIAL NEPHRITIS 5 0.0003
713 FATIGUE 207 0.0003
714 HYPOAESTHESIA ORAL 4 0.0003
715 DRUG INEFFECTIVE 348 0.0003
716 FOOT FRACTURE 5 0.0003
717 RENAL FAILURE 35 0.0003
718 DIABETES MELLITUS 20 0.0003
719 FEELING HOT 16 0.0003
720 GLAUCOMA 5 0.0003
721 OSTEOARTHRITIS 11 0.0003
722 DRUG INTOLERANCE 25 0.0003
723 HERNIA 5 0.0003
724 RASH PRURITIC 14 0.0003
725 CELLULITIS 13 0.0003
726 DELUSION 4 0.0003
727 COUGH 72 0.0003
728 BRONCHITIS 19 0.0003
729 PYREXIA 88 0.0003
730 COVID-19 PNEUMONIA 3 0.0003
731 PRODUCT USE COMPLAINT 4 0.0003
732 CONFUSIONAL STATE 41 0.0003
733 ACTIVITIES OF DAILY LIVING IMPAIRED 5 0.0003
734 NEUROPATHY PERIPHERAL 24 0.0003
735 DRUG ABUSE 21 0.0003
736 CHOLECYSTITIS 3 0.0003
737 MACULAR DEGENERATION 3 0.0003
738 SCIATICA 4 0.0003
739 WOUND 7 0.0003
740 PRODUCT USE ISSUE 47 0.0002
741 BLOOD PRESSURE FLUCTUATION 6 0.0002
742 BLISTER 14 0.0002
743 OROPHARYNGEAL PAIN 23 0.0002
744 EYE PAIN 14 0.0002
745 PRODUCT PHYSICAL ISSUE 5 0.0002
746 CHILLS 29 0.0002
747 MUSCLE TIGHTNESS 4 0.0002
748 VOMITING 116 0.0002
749 BLOOD POTASSIUM INCREASED 4 0.0002
750 DEEP VEIN THROMBOSIS 16 0.0002
751 BACK DISORDER 4 0.0002
752 DIARRHOEA 158 0.0002
753 PLATELET COUNT DECREASED 26 0.0002
754 METASTASES TO BONE 4 0.0002
755 MALAISE 106 0.0002
756 MYALGIA 41 0.0002
757 HAIR COLOUR CHANGES 3 0.0002
758 PSYCHOMOTOR HYPERACTIVITY 4 0.0002
759 HYPOAESTHESIA 36 0.0002
760 GAIT DISTURBANCE 46 0.0002
761 POLLAKIURIA 10 0.0002
762 DYSSTASIA 7 0.0002
763 DYSARTHRIA 9 0.0002
764 ANXIETY 68 0.0002
765 LABORATORY TEST ABNORMAL 7 0.0002
766 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 8 0.0002
767 INSOMNIA 63 0.0002
768 BLOOD CHOLESTEROL INCREASED 11 0.0002
769 PERIPHERAL SWELLING 36 0.0002
770 IRRITABLE BOWEL SYNDROME 5 0.0002
771 SEPSIS 26 0.0002
772 POOR QUALITY SLEEP 5 0.0002
773 APHASIA 7 0.0002
774 VAGINAL HAEMORRHAGE 10 0.0002
775 DEAFNESS 6 0.0002
776 CLOSTRIDIUM DIFFICILE INFECTION 5 0.0002
777 MUSCLE SPASMS 42 0.0002
778 METASTASES TO LIVER 4 0.0002
779 INFUSION RELATED REACTION 15 0.0002
780 ACUTE RESPIRATORY DISTRESS SYNDROME 4 0.0002
781 OFF LABEL USE 198 0.0002
782 FEMUR FRACTURE 7 0.0002
783 GENERAL PHYSICAL HEALTH DETERIORATION 26 0.0002
784 SINUSITIS 23 0.0002
785 THROAT IRRITATION 10 0.0002
786 ARTHRALGIA 92 0.0002
787 DYSPHAGIA 21 0.0002
788 LIMB INJURY 6 0.0002
789 ABDOMINAL DISTENSION 23 0.0002
790 DRUG EFFECT INCOMPLETE 8 0.0002
791 LOWER RESPIRATORY TRACT INFECTION 10 0.0002
792 CYSTITIS 7 0.0002
793 ERYTHEMA 45 0.0002
794 DYSURIA 8 0.0002
795 CONDITION AGGRAVATED 66 0.0002
796 INTENTIONAL PRODUCT USE ISSUE 19 0.0002
797 HYPOMAGNESAEMIA 3 0.0002
798 JOINT SWELLING 26 0.0002
799 AGRANULOCYTOSIS 4 0.0002
800 HAEMOPTYSIS 6 0.0002
801 APHONIA 3 0.0002
802 MASS 3 0.0002
803 THROMBOCYTOPENIA 24 0.0002
804 CHOLELITHIASIS 7 0.0002
805 PRURITUS 82 0.0002
806 DISCOMFORT 13 0.0002
807 HEPATOCELLULAR INJURY 3 0.0002
808 NERVOUSNESS 11 0.0002
809 GASTRIC ULCER 4 0.0002
810 FEELING JITTERY 4 0.0002
811 URINARY RETENTION 7 0.0002
812 NEOPLASM MALIGNANT 14 0.0002
813 EYE IRRITATION 12 0.0002
814 POST PROCEDURAL COMPLICATION 4 0.0002
815 APATHY 3 0.0002
816 FIBROMYALGIA 5 0.0002
817 PLASMA CELL MYELOMA 8 0.0002
818 LUNG DISORDER 10 0.0002
819 PSYCHOTIC DISORDER 6 0.0002
820 HEADACHE 127 0.0002
821 SINUS DISORDER 4 0.0002
822 DISORIENTATION 8 0.0002
823 VISUAL IMPAIRMENT 25 0.0002
824 DELIRIUM 7 0.0002
825 CATARACT 12 0.0002
826 COLON CANCER 3 0.0002
827 AGEUSIA 5 0.0002
828 INJECTION SITE HAEMORRHAGE 16 0.0002
829 SWELLING FACE 13 0.0002
830 PRODUCT ADMINISTRATION ERROR 4 0.0002
831 STOMATITIS 12 0.0002
832 LYMPHADENOPATHY 7 0.0002
833 TASTE DISORDER 4 0.0002
834 NEPHROLITHIASIS 9 0.0002
835 HIP ARTHROPLASTY 3 0.0002
836 MYOCARDIAL INFARCTION 34 0.0002
837 LIMB DISCOMFORT 6 0.0002
838 EXPOSURE DURING PREGNANCY 12 0.0002
839 CRYING 7 0.0002
840 BRAIN FOG 3 0.0002
841 INTENTIONAL DRUG MISUSE 4 0.0002
842 NEUTROPENIA 26 0.0002
843 MUCOSAL INFLAMMATION 5 0.0002
844 HEPATIC ENZYME INCREASED 13 0.0002
845 HALLUCINATION, AUDITORY 3 0.0002
846 ALOPECIA 37 0.0002
847 DYSPHONIA 11 0.0002
848 SURGERY 11 0.0002
849 HEPATIC FUNCTION ABNORMAL 7 0.0002
850 DRUG DOSE OMISSION 31 0.0002
851 IMPAIRED WORK ABILITY 4 0.0002
852 INFECTION 27 0.0002
853 INTERSTITIAL LUNG DISEASE 9 0.0002
854 LACTIC ACIDOSIS 6 0.0002
855 INJURY 13 0.0002
856 INCORRECT PRODUCT ADMINISTRATION DURATION 4 0.0002
857 DEPRESSION 42 0.0002
858 TREATMENT NONCOMPLIANCE 10 0.0002
859 WHITE BLOOD CELL COUNT INCREASED 7 0.0002
860 SKIN LESION 5 0.0002
861 APPLICATION SITE PAIN 4 0.0002
862 INFLUENZA 20 0.0002
863 SNEEZING 4 0.0002
864 ADVERSE DRUG REACTION 16 0.0002
865 SKIN EXFOLIATION 15 0.0002
866 CANDIDA INFECTION 3 0.0002
867 BACK PAIN 41 0.0002
868 APPLICATION SITE PRURITUS 4 0.0002
869 THROMBOSIS 14 0.0002
870 UNEVALUABLE EVENT 13 0.0002
871 COVID-19 30 0.0002
872 INCORRECT DOSE ADMINISTERED 39 0.0002
873 RHINORRHOEA 11 0.0002
874 ASCITES 5 0.0002
875 BLOOD TRIGLYCERIDES INCREASED 3 0.0002
876 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 12 0.0002
877 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 8 0.0002
878 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 30 0.0002
879 GASTROENTERITIS VIRAL 3 0.0002
880 DRY SKIN 22 0.0002
881 NEURALGIA 4 0.0002
882 DRUG ADMINISTRATION ERROR 5 0.0002
883 BLOOD GLUCOSE ABNORMAL 3 0.0002
884 PRODUCT USE IN UNAPPROVED INDICATION 40 0.0002
885 WEIGHT INCREASED 36 0.0002
886 DRY EYE 8 0.0002
887 PNEUMONIA ASPIRATION 4 0.0002
888 LEUKOPENIA 8 0.0002
889 PARAESTHESIA 25 0.0002
890 INFLUENZA LIKE ILLNESS 13 0.0002
891 FLUSHING 16 0.0002
892 INCREASED APPETITE 3 0.0002
893 WHITE BLOOD CELL COUNT DECREASED 17 0.0002
894 COLITIS ULCERATIVE 7 0.0002
895 HYPOPHAGIA 4 0.0002
896 LETHARGY 9 0.0002
897 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 4 0.0002
898 ILLNESS 16 0.0002
899 ANAPHYLACTIC SHOCK 4 0.0002
900 BLOOD GLUCOSE INCREASED 29 0.0002
901 PSORIASIS 20 0.0002
902 KIDNEY INFECTION 3 0.0002
903 RASH 66 0.0002
904 ASTHMA 17 0.0002
905 EAR INFECTION 4 0.0002
906 FUNGAL INFECTION 5 0.0001
907 THERAPEUTIC RESPONSE DECREASED 9 0.0001
908 THROAT TIGHTNESS 4 0.0001
909 PSORIATIC ARTHROPATHY 6 0.0001
910 NASOPHARYNGITIS 27 0.0001
911 MALIGNANT NEOPLASM PROGRESSION 15 0.0001
912 GASTROINTESTINAL DISORDER 13 0.0001
913 PROCEDURAL PAIN 4 0.0001
914 PAIN 88 0.0001
915 HOSPITALISATION 22 0.0001
916 DEMENTIA 4 0.0001
917 ARTHRITIS 11 0.0001
918 MOBILITY DECREASED 10 0.0001
919 SWELLING 13 0.0001
920 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 28 0.0001
921 RESTLESSNESS 5 0.0001
922 BONE PAIN 8 0.0001
923 MIGRAINE 13 0.0001
924 AGITATION 10 0.0001
925 FEBRILE NEUTROPENIA 9 0.0001
926 INTESTINAL OBSTRUCTION 5 0.0001
927 BURNING SENSATION 9 0.0001
928 DISEASE PROGRESSION 15 0.0001
929 OCULAR HYPERAEMIA 6 0.0001
930 MUSCULOSKELETAL STIFFNESS 11 0.0001
931 BLOOD GLUCOSE DECREASED 6 0.0001
932 ABORTION SPONTANEOUS 5 0.0001
933 HYPERSENSITIVITY 23 0.0001
934 EXTRA DOSE ADMINISTERED 5 0.0001
935 LIVER INJURY 3 0.0001
936 ABASIA 3 0.0001
937 THERAPEUTIC RESPONSE SHORTENED 4 0.0001
938 VISUAL ACUITY REDUCED 4 0.0001
939 GAIT INABILITY 4 0.0001
940 HOT FLUSH 9 0.0001
941 GLYCOSYLATED HAEMOGLOBIN INCREASED 3 0.0001
942 DRUG RESISTANCE 3 0.0001
943 APPLICATION SITE ERYTHEMA 3 0.0001
944 INJECTION SITE BRUISING 9 0.0001
945 THERAPY INTERRUPTED 8 0.0001
946 THERAPEUTIC RESPONSE UNEXPECTED 5 0.0001
947 DRUG EFFECT DECREASED 6 0.0001
948 SKIN IRRITATION 5 0.0001
949 ARTHROPATHY 6 0.0001
950 RENAL DISORDER 5 0.0001
951 DEATH 92 0.0001
952 INTENTIONAL DOSE OMISSION 3 0.0001
953 HYPERSOMNIA 3 0.0001
954 RASH ERYTHEMATOUS 5 0.0001
955 NASAL CONGESTION 6 0.0001
956 PRODUCT DOSE OMISSION ISSUE 30 0.0001
957 ABNORMAL BEHAVIOUR 4 0.0001
958 IRRITABILITY 6 0.0001
959 HEPATIC FAILURE 3 0.0001
960 ILL-DEFINED DISORDER 6 0.0001
961 SUICIDAL IDEATION 9 0.0001
962 LUNG NEOPLASM MALIGNANT 4 0.0001
963 UNDERDOSE 7 0.0001
964 HYPOACUSIS 4 0.0001
965 PRODUCT DOSE OMISSION 6 0.0001
966 ANAPHYLACTIC REACTION 5 0.0001
967 LIVER DISORDER 4 0.0001
968 EYE PRURITUS 3 0.0001
969 ACCIDENTAL EXPOSURE TO PRODUCT 9 0.0001
970 ADVERSE EVENT 8 0.0001
971 BREAST CANCER 8 0.0001
972 INCORRECT ROUTE OF DRUG ADMINISTRATION 3 0.0001
973 EYE SWELLING 3 0.0001
974 RHEUMATOID ARTHRITIS 9 0.0001
975 INFLAMMATION 4 0.0001
976 PROSTATE CANCER 6 0.0001
977 DEVICE BREAKAGE 3 0.0001
978 MULTIPLE SCLEROSIS RELAPSE 5 0.0001
979 DEVICE DISLOCATION 3 0.0001
980 ANGIOEDEMA 3 0.0001
981 INJECTION SITE PAIN 18 0.0001
982 ECZEMA 3 0.0001
983 PRODUCT STORAGE ERROR 5 0.0001
984 DEVICE MALFUNCTION 4 0.0001
985 MATERNAL EXPOSURE DURING PREGNANCY 5 0.0001
986 DEVICE ISSUE 5 0.0001
987 URTICARIA 9 0.0001
988 ACNE 4 0.0001
989 BLADDER CANCER 3 0.0001
990 INJECTION SITE PRURITUS 3 0.0000
991 INJECTION SITE REACTION 3 0.0000
992 NO ADVERSE EVENT 6 0.0000
993 DRUG DEPENDENCE 5 0.0000
994 EMOTIONAL DISTRESS 3 0.0000